Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome dementia complex
adverse drug reaction
agitation
akathisia
alternating hemiplegia
alternating hemiplegia of childhood
Alzheimer's disease
Alzheimer's disease, diagnosis of
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, childhood
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, familial
amyotrophic lateral sclerosis, guamian type of
amyotrophic lateral sclerosis, Parkinson-dementia-complex
amyotrophic lateral sclerosis, post-encephalitic
anticholinesterase
anxiety
areflexia
aripiprazole
ataxia
ataxia, cerebellar
ataxia, truncal
atlanto axial dislocation, congenital
ATP1A3 gene
attention span
autonomic dysfunction
Babinski sign
basal ganglia, lesion of
behavior
behavioral disorder
black box warning
bladder dysfunction
bradykinesia
bradyphrenia
brain weight
bromocriptine
CAT scan, emission
CAT scan, emission, abnormal
cavernous sinus, syndrome
cerebral cortical atrophy
cerebral glucose metabolism
cerebrospinal fluid, lactic acid concentration
cerebrospinal fluid, MHPG(3-methoxy 4-hydroxyphenyl glycol)
children
chorea
chromosome 17
Clinical Pathologic Conference(C.P.C.)
clozapine
cognition
complications
constipation
conversion reaction
cortical-basal ganglionic degeneration
cycad seed flour
degenerative diseases of CNS
dementia
dementia, age at onset
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, familial
dementia, frontotemporal
dementia, prevention of
dementia, subcortical
dementia, treatment of
deprenyl
depression
developmental milestones
developmental milestones, loss of
developmental retardation
diagnostic criteria
diet
disinhibition-dementia-parkinsonism-amyotrophic complex
donepezil
dopamine
dystonia
dystonia, post traumatic
dystonia, treatment of
efficacy
encephalocele
encephalopathy
epidemiology of neurology
evidence-based research
eye movement, disorders of
familial
fasciculation
gender
gene mutation
genetic neurologic disorders
genetic testing
granulovacuolar degeneration
hallucination
hallucination, visual
head injury
hearing loss
hemangioma
hepatomegaly
HLA
hormone replacement
hydrocephalus, normal pressure
hyperreflexia
hypotension, systemic
hypotonia
immunosuppression
inborn errors of metabolism
incidence
infantile tremor syndrome
intellectual deficit
Jakob-Creutzfeldt disease
lactic acidemia
L-dopa
L-dopa, drug interactions with and side effects of
Leigh's disease
Lewy body
Lewy body disease, diffuse
life expectancy
lobar atrophy
malformation, CNS, congenital
malformation, vascular
malformation, vascular, cerebral
medical-legal aspects of neurology
memantine
memory, impairment of
meningitis, carcinomatous
MHPG
microcephaly
mild cognitive impairment
misdiagnosis
monoamine oxidase inhibitors
motor neuron disease
motor neuron disease, juvenile form
movement disorder
movement disorder, extrapyramidal
movement disorder, hyperkinetic
MPTP
MRI
MRI, abnormal
MRI, CAT scan compared to
multiple sclerosis
multiple system atrophy
myoclonus
myoclonus, epilepsy
nausea and vomiting
neurofibrillary degeneration
neuroleptic
neuroleptic, atypical
neurologic disease, diagnoses of
neurologic signs
neuropathology
neuropathology, brain
neurotoxin
nystagmus
nystagmus, monocular
nystagmus, rotary
ophthalmoplegia
ophthalmoplegia, painful
optic atrophy
orthostatic hypotension
pallido-ponto-nigral degeneration
parietal lobe, lesion of
Parkinson disease
Parkinson disease, asymmetric onset
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, dystonia with
Parkinson disease, familial
Parkinson disease, heterogeneity of
Parkinson disease, L-dopa nonresponsive
Parkinson disease, misdiagnosis
Parkinson disease, nonmotor problems of
Parkinson disease, rapid progression
Parkinson disease, sensory symptoms in
Parkinson disease, treatment of
Parkinson disease, unilateral
Parkinson disease, young onset
Parkinsonism syndrome
Parkinsonism-dementia complex
paroxysmal hemiplegia
paroxysmal neurologic deficits
pathology
periodic paralysis
periodic paralysis, thyrotoxic
personality disorder
postural abnormality
practice guidelines
precipitating factors
premarin
prevention of neurologic disorders
prognosis
progressive subcortical gliosis
progressive supranuclear palsy
proteinopathy
psychiatric disorder
psychiatric problems in neurologic disorders
psychological testing
psychological testing, neurologic problems
psychosis
pyramidal tract dysfunction
pyruvate metabolism, abnormality of
quadriparesis
quetiapine
rapid onset dystonia parkinsonism
rapidly progressing neurologic illness
recurrent
reflex sympathetic dystrophy
REM sleep
review article
rigidity
rivastigmine
safety
salivation, excessive
seborrheic dermatitis
seizure
seizure, children
senile plaques
sensorineural hearing loss
sexual dysfunction in neurologic disease
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
Smell Identification Test
spasticity
speech, loss of
spina bifida
status epilepticus
striatonigral degeneration
striatonigral degeneration, infantile
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subarachnoid hemorrhage
synucleinopathy
tauopathy
titubation
Tolosa Hunt syndrome
torticollis, post traumatic
trauma
treatment of neurologic disorder
tremor
tremor, intention
tremor, post traumatic
tremor, treatment of
visuospatial disturbance
weight loss
Showing articles 1350 to 1400 of 3933 << Previous Next >>

A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003

Neurologic Manifestations and Outcome of West Nile Virus Infection
JAMA 290:511-515,524,558, Sejvar,J.J.,et al, 2003

Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia
Stroke 34:1907-1912, van Straaten,E.C.W.,et al, 2003

Pathological Gambling Associated with Dopamine Agonist Therapy in Parkinson's
Neurol 61:422-423, Driver-Dunckley,E.,et al, 2003

14-3-3 Protein in the CSF of Patients with Rapidly Progressive Dementia
Neurol 61:354-357, Huang,N.,et al, 2003

Prolonged Treatment for Acute Symptomatic Refractory Status Epilepticus
Neurol 61:398-401, Sahin,M.,et al, 2003

Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Arch Neurol 60:1059-1064,1043, Chen,H.,et al, 2003

Language Function and Dysfunction in Corticobasal Degeneration
Neurol 61:493-499, Graham,N.L.,et al, 2003

Donepezil in Vascular Dementia
Neurol 61:479-486,429, Helme,R.,et al, 2003

Early Alzheimer's Disease
NEJM 349:1056-1063, Kawas,C.H., 2003

Clinical Features and Neuropathology of Autosomal Dominant Spinocerebellar Ataxia (SCA17)
Ann Neurol 43:367-375, Rolfs,A.,et al, 2003

A Double-Blind Controlled Trial of Bilateral Fetal Nigral Transplantation in Parkinson's Disease
Ann Neurol 54:403-414, Olanow,C.W.,et al, 2003

Emergent EEG, Indications and Diagnostic Yield
Neurol 61:702-704, Varelas,P.N.,et al, 2003

Vascular Syndromes of the Thalamus
Stroke 34:2264-2278, Schumahmann,J.D., 2003

Diagnosing Variant Creutzfeldt-Jakob Disease with the Pulvinar Sign:"MR Imaging Findings in 86 Neuropathologically Confirmed Cases
AJNR 24:1560-1569, Collie,D.A.,et al, 2003

Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003

Awakenings From Persistent Vegetative State: Report of Three Cases With Parkinsonism and Brain Stem Lesions on MRI
JNNP 74:1571-1573, Matsuda,W.,et al, 2003

Five-Year Follow-up of Bilateral Stimulatioin of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 349:1925-1934,1888, Krack,P.,et al, 2003

End-of-Life Care and the Effects of Bereavement on Family Caregivers of Persons with Dementia
NEJM 349:1936-1942,1891, Schulz,R.,et al, 2003

Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease
NEJM 349:1812-1820, Glatzel,M.,et al, 2003

Encephalitis lethargica syndrome:20 new cases and evidence of basal ganglia autoimmunity
Brain 127, 21-33, Dale, R.C., et al, 2003

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Staging of Brain Pathology Related to Sporadic Parkinsons Disease
Neurobiol Aging 24:197-211, Braak,H.,et al, 2003

The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003

Diagnosis and Complications of Cushings Syndrome: A Consensus Statement
J Clin Endocrinol Metab 88:5593-5602, Arnaldi,G.,et al, 2003

Silent Infarcts Demonstrated by Diffusion-Weighted MRI in CADASIL
Eur Neurol 49: 178-180, Moon,S.Y.,et al, 2003

A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002

Drug-Induced Pisa Syndrome (Pleurothotomus)
CNS Drugs 10:166-174, Suzuki, T. & Matsuzaka, H., 2002

Subacute Sclerosing Panencephalitis
Postgrad Med J 78:63-70, Garg, R.K.,et al, 2002

Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction.
AJNR 23:1757-1766, Brunberg,J.A.,et al, 2002

Bilateral Subthalamic Nucleus Stimulation Improves Health-Related Quality of Life in PD
Neurol 59:1976-1978, Lagrange,E.,et al, 2002

How Valid is the Clinical Diagnosis of Parkinson's Disease in the Community?
JNNP 73:529-534, Scharg,A.,et al, 2002

Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women
JAMA 288:2123-2129,2170, Zandi,P.P.,et al, 2002

Effect of Radiotherapy and Other Treatment-Related Factors on Mid-Term to Long-Term Cognitive Sequelae in Low-Grade Gliomas: A Comparative Study
Lancet 360:1361-1368, Klein,M.,et al, 2002

Effect on Mood of Subthalamic DBS for Parkinson's Disease
Neurol 59:1427-1429, Berney,A.,et al, 2002

Mania Following Deep Brain Stimulation for Parkinson's Disease
Neurol 59:1421-1424, Kulisevsky,J.,et al, 2002

Abnormality of Gait as a Predictor of Non-Alzheimer's Dementia
NEJM 347:1761-1768, Verghese,J.,et al, 2002

Incidence and Outcome of Mild Cognitive Impairment in a Population-Based Prospective Cohort
Neurol 59;1594-1599, Larrieu,S.,et al, 2002

Driving Safety in Parkinson's Disease
Neurol 59:1787-1788, Zesiewicz,T.A.,et al, 2002

Mitochondrial Therapy for Parkinson Disease
Arch Neurol 59:1523, Rosenberg,R.N., 2002

Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002

Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002

Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002

Donepezil for Cognitive Impairment in Parkinson's Disease: A Randomised Controlled Study
JNNP 72:708-712, Aarsland,D.,et al, 2002

Incidence and Prediction of Falls in Parkinson's Disease: A Prospecitve Multidisciplinary Study
JNNP 72:721-725, Wood,B.H.,et al, 2002

Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002

Utility of Clinical Criteria in Differentiating Frontotemporal Lobar Degeneration (FTLD) From AD
Neurol 58:1608-1615, Rosen,H.J.,et al, 2002

Thalamic Venous Infarction as a Cause of Subacute Dementia
Neurol 58:1689-1691, Krolak-Salmon,P.,et al, 2002

Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002

Conspicuity and Evolution of Lesions in Creutzfeldt-Jakob Disease at Diffusion-Weighted Imaging
AJNR 23:1164-1172,1070, Murata,T.,et al, 2002



Showing articles 1350 to 1400 of 3933 << Previous Next >>